These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1562725)

  • 1. Molecular requirements for the interaction of thrombospondin with thrombin-activated human platelets: modulation of platelet aggregation.
    Legrand C; Thibert V; Dubernard V; Bégault B; Lawler J
    Blood; 1992 Apr; 79(8):1995-2003. PubMed ID: 1562725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of platelet macroaggregate formation by a recombinant heparin-binding domain of human thrombospondin.
    Legrand C; Morandi V; Mendelovitz S; Shaked H; Hartman JR; Panet A
    Arterioscler Thromb; 1994 Nov; 14(11):1784-91. PubMed ID: 7947604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteonectin is an alpha-granule component involved with thrombospondin in platelet aggregation.
    Clezardin P; Malaval L; Morel MC; Guichard J; Lecompte T; Trzeciak MC; Dechavanne M; Breton-Gorius J; Delmas PD; Kaplan C
    J Bone Miner Res; 1991 Oct; 6(10):1059-70. PubMed ID: 1796754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombospondin promotes platelet aggregation.
    Tuszynski GP; Rothman VL; Murphy A; Siegler K; Knudsen KA
    Blood; 1988 Jul; 72(1):109-15. PubMed ID: 3390605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of thrombospondin in platelet aggregation.
    Leung LL
    J Clin Invest; 1984 Nov; 74(5):1764-72. PubMed ID: 6501568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets.
    Boukerche H; McGregor JL
    Eur J Biochem; 1988 Jan; 171(1-2):383-92. PubMed ID: 3338471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional involvement of thrombospondin in platelet aggregation induced by low versus high concentrations of thrombin.
    Kao KJ; Shaut DM; Klein PA
    Thromb Haemost; 1986 Feb; 55(1):136-42. PubMed ID: 3705001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombospondin binds to the surface of human osteosarcoma cells and mediates platelet-osteosarcoma cell interaction.
    Clezardin P; Serre CM; Trzeciak MC; Drouin J; Delmas PD
    Cancer Res; 1991 May; 51(10):2621-7. PubMed ID: 1708697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex.
    Huang TF; Holt JC; Lukasiewicz H; Niewiarowski S
    J Biol Chem; 1987 Nov; 262(33):16157-63. PubMed ID: 3680247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.
    Huang TF; Liu CZ; Ouyang CH; Teng CM
    Biochem Pharmacol; 1991 Aug; 42(6):1209-19. PubMed ID: 1888330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Function of glycoprotein Ib alpha in platelet activation induced by alpha-thrombin.
    De Marco L; Mazzucato M; Masotti A; Fenton JW; Ruggeri ZM
    J Biol Chem; 1991 Dec; 266(35):23776-83. PubMed ID: 1748654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin-induced platelet aggregates have a dynamic structure. Time-dependent redistribution of glycoprotein IIb-IIIa complexes and secreted adhesive proteins.
    Heilmann E; Hourdillé P; Pruvost A; Paponneau A; Nurden AT
    Arterioscler Thromb; 1991; 11(3):704-18. PubMed ID: 2029507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin receptor occupancy modulates aggregation efficiency and platelet surface expression of vWF and thrombospondin at low thrombin concentrations.
    Kasirer-Friede A; Legrand C; Frojmovic MM
    Thromb Haemost; 1999 Jun; 81(6):967-75. PubMed ID: 10404777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High molecular weight kininogen inhibits thrombin-induced platelet aggregation and cleavage of aggregin by inhibiting binding of thrombin to platelets.
    Puri RN; Zhou F; Hu CJ; Colman RF; Colman RW
    Blood; 1991 Feb; 77(3):500-7. PubMed ID: 1846761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD36 peptides enhance or inhibit CD36-thrombospondin binding. A two-step process of ligand-receptor interaction.
    Leung LL; Li WX; McGregor JL; Albrecht G; Howard RJ
    J Biol Chem; 1992 Sep; 267(25):18244-50. PubMed ID: 1381367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the binding of thrombospondin to human platelets and its association with the platelet cytoskeleton.
    Dubernard V; Legrand C
    J Lab Clin Med; 1991 Nov; 118(5):446-57. PubMed ID: 1940585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombospondin peptides inhibit the secretion-dependent phase of platelet aggregation.
    Rabhi-Sabile S; Thibert V; Legrand C
    Blood Coagul Fibrinolysis; 1996 Mar; 7(2):237-40. PubMed ID: 8735828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor XIIIa binding to activated platelets is mediated through activation of glycoprotein IIb-IIIa.
    Cox AD; Devine DV
    Blood; 1994 Feb; 83(4):1006-16. PubMed ID: 7906563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of anti-thrombospondin monoclonal antibodies on the agglutination of erythrocytes and fixed, activated platelets by purified thrombospondin.
    Dixit VM; Haverstick DM; O'Rourke KM; Hennessy SW; Grant GA; Santoro SA; Frazier WA
    Biochemistry; 1985 Jul; 24(16):4270-5. PubMed ID: 4052397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How vitronectin binds to activated glycoprotein IIb-IIIa complex and its function in platelet aggregation.
    Mohri H; Ohkubo T
    Am J Clin Pathol; 1991 Nov; 96(5):605-9. PubMed ID: 1719797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.